Source:http://linkedlifedata.com/resource/pubmed/id/16368064
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-12-21
|
pubmed:abstractText |
Suppressor of cytokine signaling 3 (SOCS3) was reported as a feedback inhibitor of cytokine receptor signaling by inhibiting the JAK-STAT signal transduction pathway. We sought to test the anti-endotoxic septic shock effect of liposome mediated gene delivery of SOCS3 in a lethal endotoxic shock mouse model. BALB/c mice were injected intraperitoneally with 200 microg pcDNA3.1-SOCS3 cationic liposomes, while pcDNA3.1-IL-10 and empty vector as positive and negative control respectively. Forty-eight hours after gene delivery, mice were challenged with 4 microg of E.coli 0127:B8 LPS and 18 mg D-GalN administered i.p. 90 min later, serum TNF-alpha level was determined. Survival over the next 48 h was evaluated. Peritoneal macrophages from survival mice were stimulated in vitro with 1 ug/ml LPS for 18 h, and the supernatants were harvested for determination of the amount of TNF-alpha. We found that gene delivery of SOCS3 significantly increase the mouse survival rate from 27.8 +/- 9.6% of control group to 61.1 +/- 9.6% (p < 0.01). In comparison with control group (218 +/- 13 pg/ml) and sham delivery group (2,122 pg/ml), gene delivery of SOCS3 reduced the level of serum TNF-alpha (68 +/- 9 pg/ml) significantly (p < 0.01). Furthermore, gene delivery of SOCS3 displayed the capacity of prevention of tolerance of peritoneal macrophages to LPS. These findings suggest that gene delivery of SOCS3 mediated by liposome is a promising approach for endotoxic septic shock treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1672-7681
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
373-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16368064-Animals,
pubmed-meshheading:16368064-Female,
pubmed-meshheading:16368064-Gene Therapy,
pubmed-meshheading:16368064-Genetic Vectors,
pubmed-meshheading:16368064-Injections, Intraperitoneal,
pubmed-meshheading:16368064-Macrophages, Peritoneal,
pubmed-meshheading:16368064-Mice,
pubmed-meshheading:16368064-Mice, Inbred BALB C,
pubmed-meshheading:16368064-Shock, Septic,
pubmed-meshheading:16368064-Signal Transduction,
pubmed-meshheading:16368064-Suppressor of Cytokine Signaling Proteins,
pubmed-meshheading:16368064-Tumor Necrosis Factor-alpha
|
pubmed:year |
2005
|
pubmed:articleTitle |
Gene delivery of SOCS3 protects mice from lethal endotoxic shock.
|
pubmed:affiliation |
Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. minfang89@yahoo.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|